Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers.

Authors:
Jo J; Hu C; Begum K; Wang W; Le TM and 7 more

Journal:
J Infect Dis

Publication Year: 2024

DOI:
10.1093/infdis/jiad537

PMCID:
PMC10786255

PMID:
38051631

Journal Information

Full Title: J Infect Dis

Abbreviation: J Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Potential conflicts of interest. K. W. G. has received additional research grants paid to his institution from Acurx Pharmaceuticals, Seres Therapeutics, and Vendanta Biosciences and is a consultant for Ferring Pharmaceuticals. A. G. L. received research grants paid to her institution from Seres Therapeutics and is a consultant for Ferring Pharmaceuticals. All other authors report no potential conflicts.: All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed."

Evidence found in paper:

"Financial support. This work was supported by Paratek Pharmaceuticals, Inc, as an investigator-initiated grant (grant number G0505124). Funding to pay the Open Access publication charges for this article was provided by Paratek Pharmaceuticals. Financial support."

Evidence found in paper:

"Clinical Trials Registration NCT06030219."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025